Healthcare News

RSS

ProImmune collaborates with The University of Texas Medical Branch to advance infectious disease research

ProImmune, Ltd., a global leader in immunological reagents and services, today announced a collaboration with The University of Texas Medical Branch (UTMB) Galveston National Laboratory (GNL), a high-containment, infectious disease research facility, to develop innovative tools for studying high-consequence emerging and endemic infectious diseases.

From ProImmune Ltd. 15 Apr 2026

Behavioral design project aims to reduce benzodiazepine overuse

The widespread use of benzodiazepines - better known as sleeping pills or anxiety medication - among the population has become a serious public health issue.

14 Apr 2026

Feeling lonely impacts memory without accelerating mental decline

Loneliness affects the memory of older adults but does not speed up mental decline over time, suggests data from a major European study tracking more than 10,000 people over seven years.

14 Apr 2026

States change custody laws to keep children of detained immigrants out of foster care

As immigration authorities carry out what President Donald Trump has promised will be the largest mass deportation operation in U.S. history, several states are passing laws to keep children out of foster care when their detained parents have no family or friends available to take temporary custody of them.

14 Apr 2026

Study finds top AI models still struggle with clinical reasoning

Researchers tested 21 frontier large language models on 29 stepwise MSD Manual clinical vignettes and found that, although many models performed well on final diagnosis, they remained much weaker at differential diagnosis and diagnostic testing. They also introduced the PrIME-LLM score, a multidimensional benchmark designed to better capture balanced clinical reasoning across the full workflow rather than raw accuracy alone.

14 Apr 2026

Generative AI falls short in diagnostic reasoning despite accuracy

Despite increasing use of artificial intelligence (AI) in health care, a new study led by Mass General Brigham researchers from the MESH Incubator shows that generative AI models continue to fall short at their clinical reasoning capabilities.

13 Apr 2026

Supportive neighborhoods linked to slower cognitive decline in older immigrants

Older Chinese immigrants living in neighborhoods with greater access to community amenities, services and supportive infrastructure experienced slower cognitive decline over time, according to Rutgers Health researchers.

13 Apr 2026

Postpartum Medicaid expansion improved coverage but showed limited care changes

The federal policy requiring states to keep Medicaid beneficiaries enrolled during the COVID-19 pandemic extended postpartum Medicaid coverage nationwide and sharply increased the number of individuals remaining insured after childbirth, according to a Rutgers Health researcher.

13 Apr 2026

Hepatologists effectively deliver palliative care to patients with liver disease

Advanced liver disease (ALD) occurs when significant scarring causes the liver to lose function. Patients with ALD often have serious health challenges but have limited access to palliative care that could improve their quality of life.

13 Apr 2026

Retail pharmacies fill less than 2% of mifepristone orders

Just a fraction of prescriptions for the abortion pill mifepristone were filled at brick-and-mortar retail pharmacies after federal drug regulators lifted longstanding dispensing limits, according to a new USC study in JAMA.

13 Apr 2026

Study identifies intersectional biases affecting care for sickle cell patients

In season 1, episode 2 of the popular show The Pitt, a Black woman with sickle cell disease arrives at the emergency department in acute pain, only to be initially dismissed as drug-seeking.

13 Apr 2026

People with chronic pain are twice as likely to smoke cigarettes

New research from the University of Kansas shows people who experience chronic pain tend to consume cigarettes and e-cigarettes at higher rates than others.

13 Apr 2026

Standard naloxone doses may not reverse newer synthetic opioid overdoses

A new study exposes challenges in reversing opioid overdoses with naloxone when potent synthetic drugs like fentanyl and sufentanil are involved, according to a study in the May 2026 issue of Anesthesiology, the peer-reviewed medical journal of the American Society of Anesthesiologists (ASA).

13 Apr 2026

Chinese immigrants use China-based telehealth apps to overcome U.S. barriers

A new peer-reviewed study published in DIGITAL HEALTH finds that a substantial share of recent Chinese immigrants in the United States use China-based telehealth applications for medical advice while living in the U.S., often as a response to barriers within the U.S. healthcare system itself.

13 Apr 2026

Beckman Coulter Diagnostics earns CE mark for new assay delivering bacterial vs viral infection results in approximately 20 minutes

Beckman Coulter Diagnostics, a Danaher company and global leader in clinical diagnostics, today announced it has received CE 2797 mark under IVDR for the Access MeMed BV assay, enabling broad availability of a high-throughput host‑response test that helps clinicians differentiate between bacterial and viral infections in approximately 20 minutes.

From Beckman Coulter Diagnostics 13 Apr 2026

Bayer receives MHRA approval for Kerendia® (finerenone) in adults with heart failure with LVEF ≥ 40 %

The Medicines and Healthcare products Regulatory Agency (MHRA) has granted approval for Kerendia® (finerenone), a non-steroidal, selective mineralocorticoid receptor antagonist (nsMRA), for the treatment of symptomatic chronic heart failure (HF) with left ventricular ejection fraction (LVEF) ≥ 40 %, in adults in the UK.

From Bayer PLC 13 Apr 2026